These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 691678)

  • 1. [Hepatitis B and interferon].
    Oda T; Suzuki H; Mitamura K
    Nihon Rinsho; 1978 May; Suppl():2166-7. PubMed ID: 691678
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of interferon in viral hepatitis B.
    Desmyter J
    Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon therapy of hepatitis B and C].
    Jákó J
    Orv Hetil; 1995 Mar; 136(11):633. PubMed ID: 7535412
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interferon and prospects for treatment of viral hepatitis with same].
    Winogrodzka-Szaflik H
    Pol Tyg Lek; 1980 Mar; 35(10):365-7. PubMed ID: 6154289
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytokines and hepatitis].
    Degos F
    Rev Prat; 1993 Mar; 43(5):569-73. PubMed ID: 7688135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of interferon therapy in patients with chronic hepatitis].
    Papa MZ; Halperin Z; Bar Meir S
    Harefuah; 1981 Jul; 101(1-2):27-8. PubMed ID: 6172325
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection fighters. Interferon and ribavirin for hepatitis B.
    TreatmentUpdate; 2001; 12(9):2-3. PubMed ID: 12132444
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it true what they say about interferon?
    Weimar W; Schellekens H
    N Engl J Med; 1979 Apr; 300(16):923-4. PubMed ID: 423945
    [No Abstract]   [Full Text] [Related]  

  • 10. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 11. Usages of interferon and interferon inducers in man: the first half of 1980.
    Pollard RB
    Med Biol; 1980 Dec; 58(6):293-9. PubMed ID: 6164882
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?
    Alberti A
    J Hepatol; 2004 Jun; 40(6):1032-5. PubMed ID: 15158348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic hepatitis B: to treat or not to treat?].
    Fernández JL; Morgante P; Viola LA
    Acta Gastroenterol Latinoam; 1989; 19(1):53-6. PubMed ID: 2481375
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon (Egiferon) therapy of chronic active hepatitis].
    Ibrányi E; Nagy E; Szalay F; Horváth G; Dávid K
    Orv Hetil; 1993 Nov; 134(48):2645-7. PubMed ID: 7504804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
    Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
    J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
    J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
    [No Abstract]   [Full Text] [Related]  

  • 17. Usages of interferon and interferon inducers in man.
    Pollard RB
    Med Biol; 1980 Apr; 58(2):57-62. PubMed ID: 6159505
    [No Abstract]   [Full Text] [Related]  

  • 18. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 19. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA
    Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
    [No Abstract]   [Full Text] [Related]  

  • 20. [Theory and practice of pharmacotherapy of chronic hepatitis B].
    Juszczyk J
    Przegl Epidemiol; 1989; 43(2):183-91. PubMed ID: 2479056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.